EV-D68 RT-PCR Assay VP1 Gene Targeting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The lack of a rapid and specific molecular test for enterovirus D68 (EV-D68) has hindered the detection and management of outbreaks, leading to under-recognition and under-reporting of cases, as existing assays are either cumbersome or fail to distinguish between EV-D68 and closely related viruses.
Innovation Solution
A real-time reverse transcription PCR (RT-PCR) assay was developed using specific oligonucleotide primers and probes targeting the VP1 gene of EV-D68, enhancing sensitivity and specificity, allowing for the detection of divergent strains, including the 1962 Fermon strain, and improving upon existing CDC and commercial assays.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If existing molecular tests are used for EV-D68 detection, then detection can be performed, but the tests are cumbersome and require nucleotide sequencing which reduces productivity and increases complexity
Solution Approach 1:
The patent divides the detection process into specific modular components: forward primers (SEQ ID NOs: 3-6), reverse primers (SEQ ID NOs: 7-10), and probes (SEQ ID NOs: 12-17) that target specific regions of the EV-D68 genome. This segmentation allows for a streamlined RT-PCR assay that eliminates the need for comprehensive nucleotide sequencing while maintaining detection accuracy through targeted amplification of viral genetic material.
2Adaptability or versatility
If existing assays are used, then detection is possible, but they fail to distinguish between EV-D68 and closely related viruses reducing measurement precision
Solution Approach 1:
The patent applies local quality by designing primers and probes that target specific unique regions of the EV-D68 genome. The forward primers target specific sequences while the reverse primers and probes (SEQ ID NOs: 7-17) are designed to bind to distinctive viral genetic material, enabling the assay to differentiate EV-D68 from closely related enteroviruses and rhinoviruses with high specificity through localized targeted binding rather than general detection.
3Measurement precision
If RT-PCR assay with specific primers is used, then sensitivity and specificity are improved, but the complexity of assay design and validation increases
Solution Approach 1:
The patent achieves universality by creating a multi-functional RT-PCR assay system where the primer and probe sets can detect multiple EV-D68 strains including divergent strains. The assay design incorporates degenerate bases in primers (SEQ ID NOs: 3-6) that allow binding to varying viral sequences, making the single assay system universally applicable across different EV-D68 variants while maintaining simplified operation compared to multiple separate tests.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The RT-PCR assay demonstrates improved sensitivity and specificity, detecting EV-D68 at lower dilutions and earlier cycles compared to existing assays, with no cross-reactivity with closely related enteroviruses or rhinoviruses, facilitating accurate diagnosis and outbreak monitoring.
Implementation Method 1
contacting a nucleic acid obtained from the sample with an oligonucleotide primer comprising the sequence 5′-CACYGAACCAGARGAAGCCA-3′ (SEQ ID NO:3) and an oligonucleotide primer comprising the sequence 3′-AARGAATCATCCCGTCGAAATC-5′ (SEQ ID NO:4)
Implementation Method 2
exposing the contacted sample to a DNA amplification process that provides for production of a 98 nucleotide amplification product of the enterovirus D68 VP1 gene
Data Source
AI summary
The present disclosure is directed to improved methods and compositions for the detection of enterovirus D68.